CAAS News

Dr. Capone Publishes Primary Outcomes on Trauma Informed Guilt Reduction

Dr. Christy Capone and colleagues recently published primary outcomes of an RCT funded by the DoD examining a psychotherapy focused on trauma-related guilt and shame in post-9/11 veterans. Results found that Trauma Informed Guilt Reduction (TrIGR) resulted in significant reductions in guilt and PTSD and depressive symptoms as compared to Supportive Care Therapy. The research appears in the journal Depression and Anxiety.

 

Cioe Smoking Cessation Lab Starts Facebook Page

The Cioe Smoking Cessation Lab, led by Dr. Patricia Cioe, now has its very own Facebook page. Please feel free to check out www.facebook.com/CioeSmokingCessationLab/ for more information about upcoming smoking cessation studies.

Dr. Cioe Election to Board of Directors and Presented at ANAC

Dr. Patricia Cioe, Associate Professor in the Department of Social & Behavioral Sciences, was an invited speaker at the Annual Association of Nurses in AIDS Care (ANAC) conference in Washington DC, being held November 10-13, 2021. At the ANAC conference on November 11, 2021 Dr. Cioe presented, "Kicking the Habit: Innovative Interventions for Smoking Cessation in People with HIV Who Smoke" discussing her recent and ongoing work in this area.

Dr. Tara White and White Lab Presenting at SfN 2021

Dr. Tara White and her lab, the White Laboratory for Affective Neuroscience, are presenting two virtual posters & talks at the Society for Neuroscience 2021 on November 9, 2021!

Dr. Tara White Interviewed in Two Podcasts to Talk About Dignity Neuroscience

Interested in how neuroscience is relevant to wellness, flourishing & human rights?

Dr. Tara White talks about Dignity Neuroscience with Sarah Baldwin at the Watson Institute's Trending Globally podcast, and with Julie Rose at Top of Mind with BYU Radio.

Drs. Bernstein and Micalizzi Receive a Research Excellence Award

Drs. Michael Bernstein and Lauren Micalizzi (MPIs) received funding in the form of a Research Excellence Award for their study, "Precision Medicine and Open-Label Placebo (OLP): Do Genes Moderate OLP Effects?" to examine genomic predictors of open label placebos for pain among patients with upper or lower extremity fractures.

Co-investigator: Dr. McGeary.

Pages